Value of the lymphocyte nucleolar parameters for the estimation of therapy effectiveness in chronic diseases with immune lymphocyte involvement.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002466:Cell Nucleolus / Q000648:ultrastructure*; D006505:Hepatitis / Q000188:drug therapy*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008214:Lymphocytes / Q000648:ultrastructure*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D011241:Prednisone